FEBS Letters · 1988

Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+Maquart FX, Pickart L, Laurent M, et al.

Journal of Biomaterials Science, Polymer Edition · 2008

The human tri-peptide GHK and tissue remodelingPickart L

Oxidative Medicine and Cellular Longevity · 2012

The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive healthPickart L, Vasquez-Soltero JM, Margolina A

Archives of Pharmacal Research · 2007

The effect of tripeptide-copper complex on human hair growth in vitroPyo HK, Yoo HG, Won CH, et al.

International Journal of Cosmetic Science · 2002

A synthetic hexapeptide (Argireline) with antiwrinkle activityBlanes-Mira C, Clemente J, Jodas G, et al.

American Journal of Clinical Dermatology · 2013

The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled studyWang Y, Wang M, Xiao S, et al.

International Journal of Cosmetic Science · 2005

Topical palmitoyl pentapeptide provides improvement in photoaged human facial skinRobinson LR, Fitzgerald NC, Doughty DG, et al.

Biomolecules & Therapeutics · 2014

Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS)Choi YL, Park EJ, Kim E, et al.

Journal of Cosmetic Science · 2019

Effect of Palmitic Acid Conjugation on Physicochemical Properties of Peptide KTTKS: A Preformulation StudyMortazavi SM, Kobarfard F, Maibach HI, et al.

Biopharmaceutics & Drug Disposition · 1997

Skin pigmentation and pharmacokinetics of melanotan-I in humansUgwu SO, Blanchard J, Dorr RT, et al.

Expert Review of Clinical Pharmacology · 2015

Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyriaMinder EI, Schneider-Yin X

Pharmaceutical Biotechnology · 1998

Discovery and development of novel melanogenic drugs. Melanotan-I and -IIHadley ME, Hruby VJ, Blanchard J, et al.

Life Sciences · 1996

Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical studyDorr RT, Lines R, Levine N, et al.

Pharmacology, Biochemistry, and Behavior · 2006

The melanocortin agonist, melanotan II, enhances proceptive sexual behaviors in the female ratRössler AS, Pfaus JG, Kia HK, et al.

Annals of the New York Academy of Sciences · 2003

PT-141: a melanocortin agonist for the treatment of sexual dysfunctionMolinoff PB, Shadiack AM, Earle D, et al.

Bulletin of Experimental Biology and Medicine · 2003

Epithalon peptide induces telomerase activity and telomere elongation in human somatic cellsKhavinson VKh, Bondarev IE, Butyugov AA

International Journal of Cancer · 2002

Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic miceAnisimov VN, Khavinson VK, Provinciali M, et al.

Molecules · 2020

AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic MechanismKhavinson V, Diomede F, Mironova E, et al.

World Journal of Gastroenterology · 2004

Protective effects of pentadecapeptide BPC 157 on gastric ulcer in ratsXue XC, Wu YJ, Gao MT, et al.

Neural Regeneration Research · 2022

Pentadecapeptide BPC 157 and the central nervous systemVukojevic J, Milavić M, Perović D, et al.

Burns · 2005

The stable gastric pentadecapeptide BPC 157, given locally, improves CO2 laser healing in miceBilic M, Bumber Z, Blagaic AB, et al.

FASEB Journal · 2003

The actin binding site on thymosin beta4 promotes angiogenesisPhilp D, Huff T, Gho YS, et al.

FASEB Journal · 2010

Biological activities of thymosin beta4 defined by active sites in short peptide sequencesSosne G, Qiu P, Goldstein AL, et al.

The EMBO Journal · 1996

The actin binding site of thymosin beta 4 mapped by mutational analysisVan Troys M, Dewitte D, Goethals M, et al.

Inflammatory Bowel Diseases · 2008

Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel diseaseKannengiesser K, Maaser C, Heidemann J, et al.

Journal of Pharmacology and Experimental Therapeutics · 2003

Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptidesGetting SJ, Schiöth HB, Perretti M

Gastroenterology · 2008

PepT1-mediated tripeptide KPV uptake reduces intestinal inflammationDalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al.

Proceedings of the National Academy of Sciences · 1995

FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testisAgerberth B, Gunne H, Odeberg J, et al.

Blood · 2001

Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3Sørensen OE, Follin P, Johnsen AH, et al.

Biochimica et Biophysica Acta · 2006

LL-37, the only human member of the cathelicidin family of antimicrobial peptidesDürr UH, Sudheendra US, Ramamoorthy A

World Journal of Virology · 2020

Thymosin alpha 1: A comprehensive review of the literatureDominari A, Hathaway D 3rd, Pandav K, et al.

International Journal of Infectious Diseases · 2015

Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysisLi C, Bo L, Liu Q, et al.

Vitamins and Hormones · 2016

Immune Modulation with Thymosin Alpha 1 TreatmentKing R, Tuthill C

Lancet · 2022

LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trialUrva S, Coskun T, Loh MT, et al.

The New England Journal of Medicine · 2023

Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 TrialJastreboff AM, Kaplan LM, Frías JP, et al.

Lancet · 2023

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USARosenstock J, Frias J, Jastreboff AM, et al.

Molecular Metabolism · 2018

LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of conceptCoskun T, Sloop KW, Loghin C, et al.

The New England Journal of Medicine · 2021

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 DiabetesFrías JP, Davies MJ, Rosenstock J, et al.

The New England Journal of Medicine · 2022

Tirzepatide Once Weekly for the Treatment of ObesityJastreboff AM, Aronne LJ, Ahmad NN, et al.

Journal of Medicinal Chemistry · 2015

Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue SemaglutideLau J, Bloch P, Schäffer L, et al.

The New England Journal of Medicine · 2016

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesMarso SP, Bain SC, Consoli A, et al.

The New England Journal of Medicine · 2021

Once-Weekly Semaglutide in Adults with Overweight or ObesityWilding JPH, Batterham RL, Calanna S, et al.

Journal of Medicinal Chemistry · 2021

Development of Cagrilintide, a Long-Acting Amylin AnalogueKruse T, Hansen JL, Dahl K, et al.

Lancet · 2021

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trialLau DCW, Erichsen L, Francisco AM, et al.

Lancet · 2021

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trialEnebo LB, Berthelsen KK, Kankam M, et al.

Cell Metabolism · 2015

The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistanceLee C, Zeng J, Drew BG, et al.

Free Radical Biology and Medicine · 2016

MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolismLee C, Kim KH, Cohen P

Aging Cell · 2015

The mitochondrial-derived peptide MOTS-c: a player in exceptional longevity?Fuku N, Pareja-Galeano H, Zempo H, et al.

Hormone Research · 2000

Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormoneNg FM, Sun J, Sharma L, et al.

International Journal of Obesity and Related Metabolic Disorders · 2001

Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragmentHeffernan MA, Thorburn AW, Fam B, et al.

Drug Testing and Analysis · 2015

Detection and in vitro metabolism of AOD9604Cox HD, Smeal SJ, Hughes CM, et al.

Biochemical Pharmacology · 2018

Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in miceNeelakantan H, Vance V, Wetzel MD, et al.

Journal of Pharmaceutical and Biomedical Analysis · 2021

Development and validation of LC-MS/MS assay for 5-amino-1-methyl quinolinium in rat plasma: Application to pharmacokinetic and oral bioavailability studiesAwosemo O, Neelakantan H, Watowich S, et al.

Journal of Obstetrics and Gynaecology · 2021

Small molecule inhibitor of nicotinamide N-methyltransferase shows anti-proliferative activity in HeLa cellsAkar S, Duran T, Azzawri AA, et al.

Annals of Pharmacotherapy · 2012

Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophySpooner LM, Olin JL

The Journal of Clinical Endocrinology & Metabolism · 2010

Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension dataFalutz J, Mamputu JC, Potvin D, et al.

AIDS · 2008

Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulationFalutz J, Allas S, Mamputu JC, et al.

European Journal of Endocrinology · 1998

Ipamorelin, the first selective growth hormone secretagogueRaun K, Hansen BS, Johansen NL, et al.

Growth Hormone & IGF Research · 1999

Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in ratsJohansen PB, Nowak J, Skjaerbaek C, et al.

Journal of Medicinal Chemistry · 1998

A new series of highly potent growth hormone-releasing peptides derived from ipamorelinAnkersen M, Johansen NL, Madsen K, et al.

BioDrugs · 1999

Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiencyPrakash A, Goa KL

The Journal of Clinical Endocrinology & Metabolism · 1996

Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapyThorner M, Rochiccioli P, Colle M, et al.

Biochemical and Biophysical Research Communications · 1983

In vivo biological potency of rat and human growth hormone-releasing factor and fragments of human growth hormone-releasing factorWehrenberg WB, Ling N

Journal of Neuroendocrinology · 2004

Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axisThompson EL, Patterson M, Murphy KG, et al.

Journal of Cell Science · 2004

Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblastsBilban M, Ghaffari-Tabrizi N, Hintermann E, et al.

The Journal of Clinical Endocrinology and Metabolism · 2011

Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in menGeorge JT, Veldhuis JD, Roseweir AK, et al.

Bulletin of Experimental Biology and Medicine · 2003

Effect of Semax peptide on survival of cultured rat pheochromocytoma cells during oxidative stressSafarova ER, Shram SI, Zolotarev YA, et al.

Neuroscience and Behavioral Physiology · 2004

The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic systemLevitskaya NG, Sebentsova EA, Andreeva LA, et al.

Cellular and Molecular Neurobiology · 2010

Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemiaDmitrieva VG, Povarova OV, Skvortsova VI, et al.

Protein and Peptide Letters · 2018

Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological ActivityVyunova TV, Andreeva L, Shevchenko K, et al.

Bulletin of Experimental Biology and Medicine · 2022

Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in RatsKonstantinopolsky MA, Chernyakova IV, Kolik LG

Journal of Neurochemistry · 2006

Delta sleep-inducing peptide (DSIP): a still unresolved riddleKovalzon VM, Strekalova TV

Peptides · 1986

Delta-sleep-inducing peptide (DSIP): an updateGraf MV, Kastin AJ

Experientia · 1981

The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleepSchneider-Helmert D, Schoenenberger GA

Metabolism: Clinical and Experimental · 2022

Regulation of NAD(+) metabolism in aging and diseaseChu X, Raju RP

Ageing Research Reviews · 2018

NAD metabolism: Implications in aging and longevityYaku K, Okabe K, Nakagawa T

International Journal of Molecular Sciences · 2023

The Central Role of the NAD+ Molecule in the Development of Aging and the Prevention of Chronic Age-Related Diseases: Strategies for NAD+ ModulationPoljšak B, Kovač V, Špalj S, et al.

Biochimica et Biophysica Acta · 2013

Mitochondrial glutathione: features, regulation and role in diseaseMarí M, Morales A, Colell A, et al.

Antioxidants · 2020

Mitochondrial Glutathione: Recent Insights and Role in DiseaseMarí M, de Gregorio E, de Dios C, et al.

Antioxidants & Redox Signaling · 2017

Mitochondrial Glutathione: Regulation and FunctionsCalabrese G, Morgan B, Riemer J

Physiological Reviews · 2001

The oxytocin receptor system: structure, function, and regulationGimpl G, Fahrenholz F

Neuron · 2008

Oxytocin shapes the neural circuitry of trust and trust adaptation in humansBaumgartner T, Heinrichs M, Vonlanthen A, et al.

Journal of Neuroinflammation · 2019

Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in miceZhao W, Xu Z, Cao J, et al.

GeroScience · 2023

The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT)Pharaoh G, Kamat V, Kannan S, et al.

Frontiers in Cellular Neuroscience · 2017

Elamipretide (SS-31) Ameliorates Isoflurane-Induced Long-Term Impairments of Mitochondrial Morphogenesis and Cognition in Developing RatsWu J, Hao S, Sun XR, et al.

Current Medicinal Chemistry · 2011

Advances in characterization of neuroprotective peptide, humaninArakawa T, Hirano A, Shiraki K, et al.

Neuroscience Letters · 2002

Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insultsTajima H, Niikura T, Hashimoto Y, et al.

Brain Research · 2008

Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathwayXu X, Chua CC, Gao J, et al.